Cargando…

Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies

BACKGROUND: Rituximab (RTX), a monoclonal antibody that selectively binds to CD20+ B cells, showed favorable outcomes in patients with idiopathic inflammatory myopathies (IIM) in small case series, but the evidence is still not enough. Our goal was to determine the efficacy and safety of RTX for Kor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Ga Young, Suh, Chang-Hee, Kim, Yong-Gil, Park, Yong-Beom, Shim, Seung Cheol, Lee, Sang-Heon, Lee, Shin-Seok, Bae, Sang-Cheol, Yoo, Dae Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521958/ https://www.ncbi.nlm.nih.gov/pubmed/32989931 http://dx.doi.org/10.3346/jkms.2020.35.e335

Ejemplares similares

Multicenter Retrospective Analysis of the Effectiveness and Safety of Rituximab in Korean Patients with Refractory Systemic Lupus Erythematosus
por: Bang, So-Young, et al.
Publicado: (2012)

Malignancies in Korean Patients with Inflammatory Myopathy
por: Lee, Sang-Won, et al.
Publicado: (2006)

Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies
por: Yoo, Juyoung, et al.
Publicado: (2021)

Liver X receptors alpha gene (NR1H3) promoter polymorphisms are associated with systemic lupus erythematosus in Koreans
por: Jeon, Ja-Young, et al.
Publicado: (2014)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

An HLA-C amino-acid variant in addition to HLA-B*27 confers risk for ankylosing spondylitis in the Korean population
por: Kim, Kwangwoo, et al.
Publicado: (2015)

Efficacy of Rituximab in Refractory Inflammatory Myopathy Associated With Coexistence of Behçet’s Disease and Antiphospholipid Syndrome
por: Guiomar, Verónica, et al.
Publicado: (2019)

Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement
por: Kim, Miseon, et al.
Publicado: (2019)

Mortality in Korean Patients With Rheumatoid Arthritis
por: Lee, Yeon-Kyung, et al.
Publicado: (2021)

Nutritional Status and Body Composition in Korean Myopathy Patients
por: Jang, Soo Yun, et al.
Publicado: (2016)

Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma
por: Lee, Yong-Pyo, et al.
Publicado: (2021)

A Korean rheumatic diseases screening questionnaire.
por: Lee, Hye-Soon, et al.
Publicado: (2003)

Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
por: Yi, Jun Ho, et al.
Publicado: (2021)

Clinical and Radiological Features of Korean Patients With Anti-HMGCR Myopathy
por: Oh, Eun Kyoung, et al.
Publicado: (2023)

Clinical Heterogeneity in Korean Patients with Nemaline Myopathy
por: Hong, Ji-Man, et al.
Publicado: (2010)

Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator
por: Kwon, Hyeok Chan, et al.
Publicado: (2020)

Skills in Handling Turbuhaler, Diskus, and Pressurized Metered-Dose Inhaler in Korean Asthmatic Patients
por: Lee, Sang Min, et al.
Publicado: (2011)

The Korean Version of Pandemic Stress Questionnaire: Validation in Korean Population
por: Park, Sori, et al.
Publicado: (2023)

Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts
por: Yi, Jun Ho, et al.
Publicado: (2023)

Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial
por: Yoo, Dae Hyun, et al.
Publicado: (2017)

High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis
por: Lee, Jeong Seok, et al.
Publicado: (2018)

Dietary Fat Intake and the Risk of Metabolic Syndrome in Korean Adults
por: Um, Yoo-Jin, et al.
Publicado: (2015)

Use of Complementary and Alternative Medicine among Korean Cancer Patients
por: Kim, Min Jae, et al.
Publicado: (2004)

Associations Between Korean Coronary Heart Disease Risk Score and Cognitive Function in Dementia-Free Korean Older Adults
por: Mun, Hanbit, et al.
Publicado: (2022)

A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis
por: Yoo, Dae Hyun, et al.
Publicado: (2017)

Impact of Childbearing Decisions on Family Size of Korean Women with Systemic Lupus Erythematosus
por: Kim, In Je, et al.
Publicado: (2016)

Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea
por: Song, Jason Jungsik, et al.
Publicado: (2018)

Initial Preserved Renal Function as a Predictor of Favorable Renal Response to Rituximab in Refractory or Relapsing Lupus Nephritis: A Single-center Cohort Study in Korea
por: Choi, Su Jin, et al.
Publicado: (2022)

POEMS Syndrome: Bone Marrow, Laboratory, and Clinical Findings in 24 Korean Patients
por: Shim, Hyoeun, et al.
Publicado: (2019)

Association Between FcgammaR IIa and IIIa polymorphism and clinical manifestations in Korean patients with adult-onset Still's disease.
por: Oh, Young Bae, et al.
Publicado: (2002)

Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients
por: Song, Ahreum, et al.
Publicado: (2022)

Association between Metabolic Components and Subclinical Atherosclerosis in Korean Adults
por: Hwang, In Cheol, et al.
Publicado: (2012)

Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy
por: Park, Young-Eun, et al.
Publicado: (2014)

The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study
por: Byun, Jae Ho, et al.
Publicado: (2019)

Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis
por: Shin, Kichul, et al.
Publicado: (2022)

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
por: Allenbach, Yves, et al.
Publicado: (2015)

Recommendations for pathologic practice using digital pathology: consensus report of the Korean Society of Pathologists
por: Chong, Yosep, et al.
Publicado: (2020)

Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial
por: Shim, Seung Cheol, et al.
Publicado: (2019)

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth
por: Lee, Eun Ju, et al.
Publicado: (2014)

Double Autologous Stem Cell Transplantation for Multiple Myeloma: A Korean Single Center Study
por: Ko, Ock Bae, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_hb5eddq9rlj0ghn52n6oe79l3m